Drug
Insulin Detemir clinical trials
Also written Levemir and Detemir.
- studies test it
- 98
- open now
- 1
- in phase 3
- 33
- first study started
- 1999
Keep track of what changes. Save the Insulin Detemir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
97 studies that test it; most in 2008 (14)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 7 |
| 2004 | 11 |
| 2005 | 13 |
| 2006 | 8 |
| 2007 | 10 |
| 2008 | 14 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 14
- Phase 2
- 5
- Phase 3
- 33
- Phase 4
- 36
- No phase
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 62 · Other 36
Novo Nordisk A/S (59) · Diabetes Care Center (2) · University of Aarhus (2) · University of Texas Southwestern Medical Center (2) · The Royal Bournemouth Hospital (2) · Vanderbilt University (1) · University of Surrey (1) · Sydney Children's Hospitals Network (1)
Often tested with
Tested in the same studies.
Insulin Aspart (20) · Insulin Glargine (15) · Insulin, Isophane (10) · Isophane Insulin, Human (2) · Liraglutide (2) · Insulin aspart, insulin aspart protamine drug combination 30:70 (2) · NNC0363-0845 (1) · Insulin (1)
Studies
Open first, then newest update. How each study uses Insulin Detemir is read from its arms, and is right about nine times in ten.
Testing it · 98
- DETERMINE: Detemir vs NPHRecruitingPhase 2University of California, Los AngelesNCT05124457Written as Insulin Detemir
- Insulin Detemir in Obesity ManagementActive, not recruitingNot applicableVanderbilt UniversityNCT01239550Written as Detemir
- The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis PatientsTerminatedPhase 2/3University of MinnesotaNCT02496780Written as levemir insulin
- Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 DiabetesTerminatedPhase 4Centre Hospitalier Universitaire DijonNCT02048189Written as LEVEMIR
- Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in KoreaCompletedPhase 4Novo Nordisk A/SNCT00455858Written as insulin detemir
- Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00447382Written as insulin detemir
- Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00383877Written as insulin detemir
- Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00504673Written as insulin detemir
- The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OADCompletedPhase 4Novo Nordisk A/SNCT00521690Written as insulin detemir
- The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting InsulinsCompletedPhase 4Novo Nordisk A/SNCT00313742Written as insulin detemir
- Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 DiabetesTerminatedPhase 4Novo Nordisk A/SNCT00506662Written as insulin detemir
- Detemir Energy Expenditure StudyCompletedPhase 4University of SurreyNCT00788840Written as Detemir
- Cystic Fibrosis - Insulin Deficiency, Early ActionCompletedPhase 3Sydney Children's Hospitals NetworkNCT01100892Written as Once-daily insulin detemir
- A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It WorksCompletedPhase 1Novo Nordisk A/SNCT05134987Written as Insulin detemir
- Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.CompletedPhase 4Rush University Medical CenterNCT00591227Written as insulin detemir
- Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip TherapyCompletedNot applicableUniversity of Colorado, DenverNCT01186003Written as Detemir
- Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)CompletedPhase 2Wake Forest University Health SciencesNCT01595646Written as Insulin detemir
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPHTerminatedNot applicableUniversity of Texas Southwestern Medical CenterNCT00564018Written as Insulin detemir
- Evaluation of Glycemic Changes During Exercise in Children With Type 1 DiabetesCompletedNot applicableCliniques universitaires Saint-Luc- Université Catholique de LouvainNCT02824510Written as Insulin aspart, glargine and detemir
- Cooperation of Insulin and GLP-1 on Myocardial Glucose UptakeCompletedNot applicableIndiana UniversityNCT01232946Written as insulin detemir
See all 98 studies that test Insulin Detemir →
Given in every arm · 10 — Insulin Detemir is usual care beside what is tested
- MeDiGes Study: Metformine Use in Gestational DiabetesStatus unknownPhase 3Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludNCT04222348Written as Insulin Detemir
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE StudyCompletedPhase 4University of Texas Southwestern Medical CenterNCT01966978Written as Detemir
- Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01831765Written as insulin detemir
- Safety and Efficacy of Inhaled Insulin in Type 1 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00322257Written as insulin detemir
- Sitagliptin in Non-Diabetic Patients Undergoing General SurgeryCompletedPhase 4Emory UniversityNCT02741687Written as Long acting basal insulin (insulin detemir)
- Impact of Dietary Intervention on Weight Change in Subjects With Type 2 DiabetesCompletedPhase 4Novo Nordisk A/SNCT01232491Written as Insulin detemir
- Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00789191Written as insulin detemir
- Safety and Efficacy of Inhaled Insulin in Type 2 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00331604Written as insulin detemir
- Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenCompletedPhase 4Novo Nordisk A/SNCT01165684Written as insulin detemir
- A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 DiabetesCompletedPhase 4AstraZenecaNCT00467649Written as basal insulin (Lantus® [insulin glargine], or Levemir® [insulin detemir])
As the comparator · 17 — what is tested is compared with Insulin Detemir
- A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 DiabetesCompletedPhase 1Novo Nordisk A/SNCT06685185Written as Insulin detemir
- Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03377699Written as Insulin detemir
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating InsulinCompletedPhase 4SanofiNCT02967224Written as insulin detemir
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal InsulinCompletedPhase 4SanofiNCT02967211Written as insulin detemir
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)CompletedPhase 4SanofiNCT02451137Written as Insulin detemir
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes MellitusCompletedPhase 3Novo Nordisk A/SNCT01835431Written as insulin detemir
- A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal InsulinTerminatedPhase 3Novo Nordisk A/SNCT02131272Written as Insulin detemir
- Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00978627Written as insulin detemir
- Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01074268Written as insulin detemir
- Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 DiabetesCompletedPhase 2Novo Nordisk A/SNCT00841087Written as insulin detemir
- The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic OriginCompletedPhase 1Novo Nordisk A/SNCT01043510Written as insulin detemir
- A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 DiabetesCompletedPhase 1Novo Nordisk A/SNCT01135927Written as insulin detemir
- Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 DiabetesCompletedPhase 4University of FloridaNCT00998335Written as Long-acting bedtime insulin detemir (Levemir)
- Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 DiabetesCompletedPhase 3AstraZenecaNCT01003184Written as insulin detemir
- Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal InsulinStatus unknownNot applicableFudan UniversityNCT01310452Written as insulin detemir
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)CompletedPhase 3Eli Lilly and CompanyNCT00494013Written as Detemir
- Lantus Versus Levemir Treat-To-TargetCompletedPhase 4SanofiNCT00405418Written as Insulin Detemir
Codes
What other systems call Insulin Detemir · ClinicalTrials.gg INT006564
- MeSH (NLM) D000069057Insulin DetemirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 4FT78T86XVINSULIN DETEMIRConfirmed FDA, NLM, Wikidata
- RxNorm 139825Confirmed FDA, Wikidata
- Wikidata Q410965insulin detemirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65920Insulin DetemirConfirmed FDA, Wikidata
- DrugBank DB01307One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069057 | Insulin Detemir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 4FT78T86XV | INSULIN DETEMIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 139825 | — | Confirmed FDA, Wikidata |
| Wikidata | Q410965 | insulin detemir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65920 | Insulin Detemir | Confirmed FDA, Wikidata |
| DrugBank | DB01307 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.